 Connection
Breelyn Wilky to Receptors, TNF-Related Apoptosis-Inducing Ligand
This is a "connection" page, showing publications Breelyn Wilky has written about Receptors, TNF-Related Apoptosis-Inducing Ligand.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.231 |
|
|
|
-
Subbiah V, Chawla SP, Conley AP, Wilky BA, Tolcher A, Lakhani NJ, Berz D, Andrianov V, Crago W, Holcomb M, Hussain A, Veldstra C, Kalabus J, O'Neill B, Senne L, Rowell E, Heidt AB, Willis KM, Eckelman BP. Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma. Clin Cancer Res. 2023 08 15; 29(16):2988-3003.
Score: 0.231
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|